As GLP-1 Brands Go Prime Time, Regulators Flag Growing Illicit Market GLP-1 weight loss drugs have moved from medical breakthrough to a mainstream cultural phenomenon, but regulators warn consumers of a growing market for illicit and counterfeit products
Key takeaways Semaglutide is the active ingredient in the brand-name drugs Ozempic, Wegovy, and Rybelsus
In compliance with regulatory requirements, retatrutide access is currently limited to research purposes and is not approved for general or commercial use
Recent studies suggest that ALA IV therapy may also benefit individuals with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
Peptides and SARMs | Side Effects and Safety
With a guided approach, it is possible to restore balance, improve overall health, and regain vitality